English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/95826
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Adamantane substituted aminocyclitols as pharmacological chaperones for Gaucher disease

AuthorsTrapero, Ana; Egido-Gabás, Meritxell; Llebaria, Amadeu
Issue Date2013
CitationMedicinal Chemistry Communication 4: 1584- 1589 (2013)
AbstractGaucher disease (GD), resulting from deficient lysosomal enzyme β-glucosidase (GCase) activity, is the most common lysosomal storage disorder. We have previously shown that aminocyclitol derivatives displayed selective inhibition of GCase and enhanced GCase activity in N370S and L444P at very low concentrations. In the present study, we combined amino-myo-inositol and amino-scyllo-inositol cores with a hydrophobic alkyl adamantyl amide to afford novel small molecules with enhanced ability to increase GCase activity in GD lymphoblasts. The most potent inhibitor, amino-myo-inositol 2, displayed a Ki value of 250 nM in isolated enzyme. This compound produced a maximum increase of GCase activity of 64% in N370S lymphoblasts at 1 μM and 150% in L444P at 100 μM following a 3 day incubation. © 2013 The Royal Society of Chemistry.
Identifiersdoi: 10.1039/c3md00217a
issn: 2040-2503
Appears in Collections:(IQM) Artículos
(IQAC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.